tiprankstipranks
Advertisement
Advertisement

EKF Diagnostics Updates Total Voting Rights After Share Capital Review

Story Highlights
EKF Diagnostics Updates Total Voting Rights After Share Capital Review

Claim 30% Off TipRanks

EKF Diagnostics Holdings ( (GB:EKF) ) has issued an announcement.

EKF Diagnostics Holdings has confirmed that its total issued share capital stands at 431,963,112 ordinary shares of 1p each, of which 141,000 are held in treasury and do not carry voting rights. This leaves 431,822,112 ordinary shares with voting rights, a figure that investors must now use to assess whether they are required to disclose new or changed holdings under the Financial Conduct Authority’s transparency rules.

The updated share count clarifies EKF’s current capital and voting structure, giving shareholders and potential investors greater certainty when calculating percentage stakes. By formally notifying the market, the diagnostics group reinforces compliance with U.K. disclosure requirements, which is important for maintaining orderly trading and clear oversight of significant positions in its stock.

The most recent analyst rating on (GB:EKF) stock is a Hold with a £26.00 price target. To see the full list of analyst forecasts on EKF Diagnostics Holdings stock, see the GB:EKF Stock Forecast page.

Spark’s Take on GB:EKF Stock

According to Spark, TipRanks’ AI Analyst, GB:EKF is a Neutral.

EKF Diagnostics Holdings receives a score of 67, driven by strong financial performance and a positive earnings call. The company’s robust balance sheet and improved profitability are significant strengths. However, technical indicators suggest potential bearish momentum, and the valuation is moderate. The positive outlook from the earnings call, including strategic growth plans and a share buyback program, enhances the overall score.

To see Spark’s full report on GB:EKF stock, click here.

More about EKF Diagnostics Holdings

EKF Diagnostics Holdings is an AIM-listed global diagnostics company focused on point-of-care analysers in hematology and diabetes, as well as life sciences services that manufacture specialist enzymes and custom products for diagnostic, food and industrial applications. Headquartered in Penarth near Cardiff, it operates five manufacturing sites across the U.S. and Germany and sells into more than 120 countries worldwide.

Average Trading Volume: 266,847

Technical Sentiment Signal: Sell

Current Market Cap: £111.4M

See more data about EKF stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1